title: BIOMARKERS OF HEART FAILURE IN PEDIATRIC PRACTICE
abstract: Highlights In pediatrics, biomarkers of heart failure (HF) are particularly important for early detection and risk stratification of patients with systemic diseases and the associated risk of early development of HF. New biomarkers have certain prognostic advantages, but also some limitations, especially in pediatrics due to low specificity and insufficient data on long-term use. Thus, the prognostic value of these biomarkers has not been fully confirmed and requires further study for wide clini
journal: Complex Issues of Cardiovascular Diseases